Abstract:Genome sequences of marine streptomycetes are valuable for the discovery of useful enzymes and bioactive compounds by genome mining. However, publicly available complete genome sequences of marine streptomycetes are still limited. Here, we present the complete genome sequence of a marine streptomyceteStreptomycessp. S063 CGMCC 14582. Species delineation based on the pairwise digital DNA-DNA hybridization and genome comparison ANI (average nucleotide identity) value showed thatStreptomycessp. S063 CGMCC 14582 possesses a unique genome that is clearly different from all of the other available genomes. Bioactivity tests showed thatStreptomycessp. S063 CGMCC 14582 produces metabolites with anti-complement activities, which are useful for treatment of numerous diseases that arise from inappropriate activation of the human complement system. Analysis of the genome reveals no biosynthetic gene cluster (BGC) which shows even low similarity to that of the known anti-complement agents was detected in the genome, indicating thatStreptomycessp. S063 CGMCC 14582 may produce novel anti-complement agents of microbial origin. Four BGCs which are potentially involved in biosynthesis of non-ribosomal peptides were disrupted, but no decrease of anti-complement activities was observed, suggesting that these four BGCs are not involved in biosynthesis of the anti-complement agents. In addition, LC-MS/MS analysis and subsequent alignment through the Global Natural Products Social Molecular Networking (GNPS) platform led to the detection of novel peptides produced by the strain.Streptomycessp. S063 CGMCC 14582 grows rapidly and is salt tolerant, which benefits efficient secondary metabolite production via seawater-based fermentation. Our results indicate thatStreptomycessp. S063 has great potential to produce novel bioactive compounds, and also is a good host for heterologous production of useful secondary metabolites for drug discovery.

Draft genome sequence of marine Streptomyces sp. strain W007, which produces angucyclinone antibiotics with a benz[a]anthracene skeleton.

Genomic sequence-based discovery of novel angucyclinone antibiotics from marine Streptomyces sp. W007.

Complete Genome Sequence of Streptomyces Sp. HNA39, a New Cyclizidine Producer Isolated from a South China Sea Sediment.

Metabolic Blockade-Based Genome Mining of Sea Anemone-Associated Streptomyces sp. S1502 Identifies Atypical Angucyclines WS-5995 A–E: Isolation, Identification, Biosynthetic Investigation, and Bioactivities

Complete Genome Sequence of Streptomyces Spongiicola HNM0071T, a Marine Sponge-Associated Actinomycete Producing Staurosporine and Echinomycin

Draft Genome Sequence of the Marine Streptomyces Sp Strain Pp-C42, Isolated from the Baltic Sea

Discovery of Angucyclinone Polyketides from Marine Actinomycetes with a Genomic DNA-based PCR Assay Targeting Type II Polyketide Synthase

Angucycline antibiotics and its derivatives from marine-derived actinomycete Streptomyces sp. A6H

Draft Genome Sequence of the Anti-Algal Marine Actinomycete Streptomyces Sp. JS01.

Two glucosylated angucyclines from deep-sea-derived Streptomyces sp.PKU-MA01297

Genome mining-directed activation of a silent angucycline biosynthetic gene cluster in Streptomyces chattanoogensis.

Angucyclines and Angucyclinones from Streptomyces Sp. CB01913 Featuring C-Ring Cleavage and Expansion.

Streptomyces spp. From the Marine Sponge Antho dichotoma: Analyses of Secondary Metabolite Biosynthesis Gene Clusters and Some of Their Products

Draft Genome Sequence of the Marine-Derived, Anticancer Compound-Producing Bacterium Streptomyces sp. Strain GMY01

Antibiotic Angucycline Derivatives from the Deepsea-Derived Streptomyces Lusitanus

OSMAC-Based Discovery and Biosynthetic Gene Clusters Analysis of Secondary Metabolites from Marine-Derived Streptomyces globisporus SCSIO LCY30

A New Medermycin Analog from the Marine-Derived Actinomycetes Streptomyces Sp. ZS-A45.

Deciphering the Streamlined Genome of Streptomyces Xiamenensis 318 As the Producer of the Anti-Fibrotic Drug Candidate Xiamenmycin

Analysis of the Complete Genome Sequence of a Marine-Derived Strainstreptomycessp. S063 CGMCC 14582 Reveals Its Biosynthetic Potential to Produce Novel Anti-Complement Agents and Peptides

Complete Genome Sequence of Streptomyces Sp. CNQ-509, a Prolific Producer of Meroterpenoid Chemistry

Genome sequence of Streptomyces auratus strain AGR0001, a phoslactomycin-producing actinomycete